These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 21214147)
1. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin. Kim JW; Yau JW; Moshfeghi D; Fishman M J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147 [TBL] [Abstract][Full Text] [Related]
2. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP; Honavar SG; Reddy VA; Khanna R Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675 [TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [TBL] [Abstract][Full Text] [Related]
4. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125 [TBL] [Abstract][Full Text] [Related]
5. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514 [TBL] [Abstract][Full Text] [Related]
6. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Demirci H; Eagle RC; Shields CL; Shields JA Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690 [TBL] [Abstract][Full Text] [Related]
7. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261 [TBL] [Abstract][Full Text] [Related]
8. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319 [TBL] [Abstract][Full Text] [Related]
10. What is the best treatment for retinoblastoma? Harbour JW Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232 [No Abstract] [Full Text] [Related]
14. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213 [TBL] [Abstract][Full Text] [Related]
15. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977 [TBL] [Abstract][Full Text] [Related]
16. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation. Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA Retina; 2013; 33(10):2103-9. PubMed ID: 23873161 [TBL] [Abstract][Full Text] [Related]